Health
Medical
Cancer Prevention

Cancer Genetics

$0.1213
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0013 (1.08%) As of 1:57 PM EDT today
+$0.0013 (1.08%) Today

Why Robinhood?

You can buy or sell CGIX and other stocks, options, ETFs, and crypto commission-free!

About CGIX

Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. Read More The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.

Employees
168
Headquarters
Rutherford, New Jersey
Founded
1999
Market Cap
6.94M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.64M
High Today
$0.1276
Low Today
$0.1135
Open Price
$0.115
Volume
1.22M
52 Week High
$1.30
52 Week Low
$0.1045

Collections

Health
Medical
Cancer Prevention
Consulting
Business Services
2013 IPO
US
North America

CGIX Earnings

-$0.90
-$0.60
-$0.31
-$0.01
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
-$0.01 per share

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.